Creative Planning’s Achillion Pharmaceuticals ACHN Stock Holding History

Creative Planning’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-400	Closed	-$1K	–	4490
2014 Q4	$1K	Sell	400 -600	-60%	-$7.33K	﹤0.01%	4044
2014 Q3	$1K	Sell	1,000 -10,000	-91%	-$92.8K	﹤0.01%	3903
2014 Q2	$39K	Buy	+11,000	New	+$43.9K	﹤0.01%	2051

Creative Planning's ACHN Position: Q1 2020 in Review

Creative Planning sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 128,976 shares — an estimated $778K sold.

Creative Planning first reported a position in ACHN in Q3 2013 and held it in 26 quarters. The position peaked at $1.28M in Q3 2016. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Creative Planning reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Creative Planning sold 128,976 Achillion Pharmaceuticals shares in Q1 2020, an estimated $778K.
Creative Planning first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 26 quarters.
Creative Planning's Achillion Pharmaceuticals position peaked at $1.28M in Q3 2016.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.